Zoetis (ZTS) Cash from Investing Activities Growth (1y) (2013 - 2026)
Zoetis (ZTS) Cash from Investing Activities Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 827.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.14% |
| Dec 31, 2025 | -231.75% |
| Sep 30, 2025 | 10.11% |
| Jun 30, 2025 | -65.91% |
| Mar 31, 2025 | -54.96% |
| Dec 31, 2024 | 160.00% |
| Sep 30, 2024 | 34.32% |
| Jun 30, 2024 | -65.00% |
| Mar 31, 2024 | 39.35% |
| Dec 31, 2023 | 52.05% |
| Sep 30, 2023 | -118.55% |
| Jun 30, 2023 | 60.59% |
| Mar 31, 2023 | -83.05% |
| Dec 31, 2022 | -208.45% |
| Sep 30, 2022 | -8.77% |
| Jun 30, 2022 | -46.04% |
| Mar 31, 2022 | -87.30% |
| Dec 31, 2021 | 19.77% |
| Sep 30, 2021 | 34.48% |
| Jun 30, 2021 | 15.24% |